carbachol has been researched along with Arteriosclerosis Obliterans in 1 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Arteriosclerosis Obliterans: Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ziganshin, AU | 1 |
| Khaziakhmetov, DF | 1 |
| Ziganshina, LE | 1 |
| Khaziakhmetova, VN | 1 |
| Jourjikiya, RK | 1 |
| Ziganshin, BA | 1 |
| Giniyatova, LR | 1 |
| Burnstock, G | 1 |
1 other study available for carbachol and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
Varicose disease affects the P2 receptor-mediated responses of human greater saphenous vein.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Animals; Arteriosclerosis Obliterans; Carbacho | 2004 |